Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: Potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia

This publication has 24 references indexed in Scilit:

• Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
  Circulation, 1982
• Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone
  American Heart Journal, 1981
• Amiodarone in the treatment of cardiac arrhythmias in children: One hundred thirty-five cases
  American Heart Journal, 1980
• New perspectives in the pharmacologic therapy of cardiac arrhythmias
  Progress in Cardiovascular Diseases, 1980
• Clinical efficacy of amiodarone as an antiarrhythmic agent
  The American Journal of Cardiology, 1976
• EFFECTS OF AMIODARONE AND L8040, NOVEL ANTIANGINAL AND ANTIARRHYTHIC DRUGS, ON CARDIAC AND CORONARY HAEMODYNAMICS AND ON CARDIAC INTRACELLULAR POTENTIALS
  Clinical and Experimental Pharmacology and Physiology, 1976
• Effect of amiodarone in the Wolff-Parkinson-White syndrome
  The American Journal of Cardiology, 1976
• Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride
  The American Journal of Cardiology, 1974
• Comparative mechanisms of action of antiarrhythmic drugs
  American Heart Journal, 1974
• The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle
  British Journal of Pharmacology, 1970